phone+44 203 371 1100

Glaxosmithkline Plc

Credit Sector:- Health Care

Country:- United Kingdom

Bond Document:- https://www.bondpdf.com

In order to view the complete data, please login here

List of Corporate Actions

Announcement Date CA Type CA Impact CA Event ISIN
06-Apr-2020 Offer Purchase Stock Target Name Vir Biotechnology, Inc. US00214WAE12
Glaxosmithkline Plc today announced that it intends to make an equity investment of $250 million in Vir Biotechnology, Inc.
13-Apr-2022 Propose Acquisition Target Name Sierra Oncology, Inc. US00214WAE12
Glaxosmithkline Plc has announced that it intends to acquire Sierra Oncology, Inc.
25-May-2022 Red Code Change Target Name GSK Plc US00214WAE12
Glaxosmithkline Plc (3AEA6Z) red code has been changed to GK625K as a result of name change to GSK Plc
16-May-2022 Name Change Old Name Glaxosmithkline Plc -
GSK Plc today announced that it has changed its company name from Glaxosmithkline Plc.
16-May-2022 Name Change New Name GSK Plc -
Glaxosmithkline Plc today announced that it has changed its company name to GSK Plc.

View more details

FactEntry

All of the financial data available on this page is sourced from FactEntry.